Equities

Sihuan Pharmaceutical Holdings Group Ltd

Sihuan Pharmaceutical Holdings Group Ltd

Actions
  • Price (EUR)0.054
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-18.80%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,3684,7925,792
Total Receivables, Net1,0459781,094
Total Inventory647748855
Prepaid expenses------
Other current assets, total14433--
Total current assets6,2046,5507,741
Property, plant & equipment, net2,8422,9984,093
Goodwill, net1.851.8528
Intangibles, net776626596
Long term investments1,2501,1281,197
Note receivable - long term320579377
Other long term assets------
Total assets11,53512,14114,496
LIABILITIES
Accounts payable221206119
Accrued expenses4296291,058
Notes payable/short-term debt02630
Current portion long-term debt/capital leases282314175
Other current liabilities, total3,1751,3581,120
Total current liabilities4,1072,5332,502
Total long term debt894929876
Total debt1,1761,2691,081
Deferred income tax7099222
Minority interest705903866
Other liabilities, total1,3272,9401,745
Total liabilities7,1037,4046,211
SHAREHOLDERS EQUITY
Common stock777777
Additional paid-in capital3,8823,8823,882
Retained earnings (accumulated deficit)5077784,325
Treasury stock - common(34)----
Unrealized gain (loss)------
Other equity, total------
Total equity4,4324,7378,284
Total liabilities & shareholders' equity11,53512,14114,496
Total common shares outstanding9,3309,3309,330
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.